GEXVal to Present at BIO Asia-Taiwan 2024 Investment Summit
2024/7/12
GEXVal Inc.July 12, 2024 GEXVal to Present at BIO Asia-Taiwan 2024 Investment Summit GEXVal Inc. will be p […]
GEXVal Completes Phase I Clinical Trial of GXV-001 in Australia
2024/7/1
GEXVal Inc.July 1, 2024 GEXVal Completes Phase I Clinical Trial of GXV-001 in Australia We are pleased to anno […]
GEXVal CEO Delivers Lecture at Kindai University*
2024/6/29
GEXVal Inc.June 29, 2024 GEXVal CEO Delivers Lecture at Kindai University* Juran Kato, PhD, President and […]
GEXVal Completes Additional Funding of JPY 110 Million in Series C Extension Round
2024/6/25
―To Accelerate Development in Australia and Expand the Pipeline― GEXVal Inc.June 25, 2024 GEXVal Completes A […]
GEXVal Sponsors SLTBR 2024 35th Annual Meeting
2024/6/18
GEXVal Inc.June 18, 2024 GEXVal Sponsors SLTBR 2024 35th Annual Meeting GEXVal Inc. is proud to sponsor the 35 […]